Pathogenetic prerequisites for the use of drugs regulating mechanisms of blood coagulation and fibrinolysis in ophthalmology.
D000925:Anticoagulants / Q000627:therapeutic use*; D000933:Antifibrinolytic Agents / Q000627:therapeutic use*; D005128:Eye Diseases / Q000188:drug therapy*; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D006801:Humans; D012166:Retinal Hemorrhage / Q000188:drug therapy; D013927:Thrombosis / Q000188:drug therapy
D000925:Anticoagulants; D000933:Antifibrinolytic Agents; D005343:Fibrinolytic Agents